Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

543 ARTÍCULOS , VIENDO DEL 151 AL 165

Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial

Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators.

JAMA Neurol. 2022 Aug 1;79(8):758-767. doi: 10.1001/jamaneurol.2022.1375.

Deep brain stimulation of fornix for memory improvement in Alzheimer's disease: A critical review

Li R, Zhang C, Rao Y, Yuan TF.

Ageing Res Rev. 2022 Aug;79:101668. doi: 10.1016/j.arr.2022.101668. Epub 2022 Jun 12.

Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease

Wang X, Wei S, Zhao C, Li X, Jin J, Shi X, Su Z, Li J, Wang J.

J Biol Inorg Chem. 2022 Aug;27(4-5):405-419. doi: 10.1007/s00775-022-01942-7. Epub 2022 Jun 17.

Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents

George N, Jawaid Akhtar M, Al Balushi KA, Alam Khan S.

Bioorg Chem. 2022 Oct;127:105941. doi: 10.1016/j.bioorg.2022.105941. Epub 2022 Jun 10.

Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial

Valenzuela M, Duncan T, Abey A, Johnson A, Boulamatsis C, Dalton MA, Jacobson E, Brunel L, Child G, Simpson D, Buckland M, Lowe A, Siette J, Westbrook F, McGreevy P.

Stem Cell Res Ther. 2022 Jun 17;13(1):261. doi: 10.1186/s13287-022-02933-w.

Adipose tissue-derived stem cells as a potential candidate in treatment of Alzheimer's disease: A systematic review on preclinical studies

Madani Neishaboori A, Eshraghi A, Tasouji Asl A, Shariatpanahi M, Yousefifard M, Gorji A.

Pharmacol Res Perspect. 2022 Aug;10(4):e00977. doi: 10.1002/prp2.977.

Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease

Liu Y, Cheng X, Li H, Hui S, Zhang Z, Xiao Y, Peng W.

Front Immunol. 2022 Jun 2;13:908076. doi: 10.3389/fimmu.2022.908076. eCollection 2022.

Anti-amyloid agents for treating incipient Alzheimer's disease: a new hope?

Loureiro JC, Silva LFAL, Pais MV, Forlenza OV.

Braz J Psychiatry. 2022 Aug 20;44(4):368-369. doi: 10.47626/1516-4446-2022-2503.

Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findings

Delbreil P, Rabanel JM, Banquy X, Brambilla D.

Adv Drug Deliv Rev. 2022 Aug;187:114397. doi: 10.1016/j.addr.2022.114397. Epub 2022 Jun 20.

Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease

Li Q, Rubin L, Silva M, Li S, Yang C, Lazarovici P, Zheng W.

Oxid Med Cell Longev. 2022 Jun 14;2022:3777021. doi: 10.1155/2022/3777021. eCollection 2022.

Targeting gut microbiota to alleviate neuroinflammation in Alzheimer's disease

Thu Thuy Nguyen V, Endres K.

Adv Drug Deliv Rev. 2022 Sep;188:114418. doi: 10.1016/j.addr.2022.114418. Epub 2022 Jul 3.

Efficacy and safety of sodium oligomannate in the treatment of Alzheimer's disease

Zhang LF, Zhang YP, Lin PX, Xue LH.

Pak J Pharm Sci. 2022 May;35(3):741-745.

How a Medicare payment model is affecting care for older adults with Alzheimer's disease and related dementias

Hung A, Hall R.

J Am Geriatr Soc. 2022 Sep;70(9):2478-2480. doi: 10.1111/jgs.17948. Epub 2022 Jul 6.

Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer's Disease

Tedeschi P, Nigro M, Travagli A, Catani M, Cavazzini A, Merighi S, Gessi S.

Int J Mol Sci. 2022 Jun 22;23(13):6950. doi: 10.3390/ijms23136950.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias